Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin.
Diabetes Obes Metab
; 15(3): 280-3, 2013 Mar.
Article
in En
| MEDLINE
| ID: mdl-23061428
Full text:
1
Database:
MEDLINE
Main subject:
Rifampin
/
Mefenamic Acid
/
Glucuronosyltransferase
/
Diabetes Mellitus, Type 2
/
Enzyme Inhibitors
/
Sodium-Glucose Transporter 2 Inhibitors
/
Glucosides
/
Hypoglycemic Agents
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Diabetes Obes Metab
Journal subject:
ENDOCRINOLOGIA
/
METABOLISMO
Year:
2013
Type:
Article
Affiliation country:
United States